Physician profile
Robert A Pringle
NPI 1124011424
$5,098.53
in general payments reported to CMS, 2019-2025
37 companies · $961 in 2025
The $961 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,174 · 2020: $276 · 2021: $451 · 2022: $322 · 2023: $1,119 · 2024: $796 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,876.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $771.13 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $662.91 | 2019-2025 | Amplatzer Amulet, Jot Dx, Gallant |
| Novartis Pharmaceuticals Corporation | $470.67 | 2019-2025 | |
| Philips North America LLC | $362.96 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions, (5091) Amb Mon & Diag Und |
| Amgen INC. | $348.91 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $290.88 | 2019-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $252.26 | 2019-2024 | Xarelto |
| Pfizer INC. | $242.77 | 2019-2025 | |
| Boston Scientific Corporation | $155.94 | 2019-2023 | Watchman Access System, Bodyguardian |
| Novo Nordisk INC | $154.15 | 2024-2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.68 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $127.42 | 2019-2021 | |
| Astellas Pharma US INC | $101.61 | 2019-2021 | |
| Scpharmaceuticals INC. | $101.44 | 2023-2025 | |
| Irhythm Technologies, INC. | $98.83 | 2023-2024 | Zio Xt Patch, Zio Monitor |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pringle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.